Scientists at Cedars-Sinai have found something unexpected hiding in plain sight: cells called astrocytes that sit far away from a spinal cord injury actually help repair it. The discovery, published in Nature, suggests a new angle for treating spinal cord damage, stroke, and diseases like multiple sclerosis.
For decades, researchers assumed the action happened at the injury site itself. But Joshua Burda and his team discovered that astrocytes positioned well away from the damage—they call them "lesion-remote astrocytes"—spring into action when injury occurs. These distant cells send out chemical signals that essentially tell the immune system how to clean up the mess.
How the cleanup works
When a spinal cord is injured, nerve fibers snap and die, leaving behind fatty debris. The immune cells responsible for cleanup, called microglia, struggle with this fat-heavy garbage. They get what Burda describes as "a kind of indigestion." The astrocytes solve this by releasing a protein called CCN1 that signals the microglia to change their metabolism—essentially teaching them to digest fat more efficiently.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News Detox
The research team tested this in laboratory mice with spinal cord injuries and found strong evidence that these distant astrocytes were critical to recovery. When they looked at human tissue samples from spinal cord injury patients, the same mechanism was at work. The implications matter because many people with spinal cord injuries do experience some spontaneous recovery—this astrocyte-driven cleanup might explain why.
When the researchers blocked the CCN1 signal in mice, recovery got noticeably worse. That suggests the pathway isn't just a nice-to-have; it's fundamental to healing.
A wider window
Burda's team found the same process operating in tissue from patients with multiple sclerosis. This hints that the discovery applies broadly to any central nervous system injury or disease—not just spinal cord damage. The work also reveals why astrocytes have been so understudied: their role in healing happens at a distance, in ways that weren't obvious until now.
The next phase is already underway. Burda is working to harness the CCN1 mechanism deliberately—essentially asking whether boosting this natural repair process could improve outcomes after injury or slow the progression of neurodegenerative disease. If that works, it would mean turning a cell's existing behavior into a treatment, rather than inventing something entirely new.
